You no longer need to seek preauthorization approval before administering bone mineral density (BMD) screenings to your ConnectiCare commercial and Medicare Advantage patients.
As a reminder, all women over the age of 65 should have a bone mineral density test every two years to help prevent or treat osteoporosis.
